Unknown

Dataset Information

0

Drug combination screening as a translational approach toward an improved drug therapy for chordoma.


ABSTRACT:

Purpose

Drug screening programmes have revealed epidermal growth factor receptor inhibitors (EGFRis) as promising therapeutics for chordoma, an orphan malignant bone tumour, in the absence of a known genetic driver. Concurrently, the irreversible EGFRi afatinib (Giotrif®) is being evaluated in a multicentric Phase II trial. As tyrosine kinase inhibitor (TKI) monotherapies are invariably followed by resistance, we aimed to evaluate potential therapeutic combinations with EGFRis.

Methods

We screened 133 clinically approved anticancer drugs as single agents and in combination with two EGFRis (afatinib and erlotinib) in the clival chordoma cell line UM-Chor1. Synergistic combinations were analysed in a 7 × 7 matrix format. The most promising combination was further explored in clival (UM-Chor1, MUG-CC1) and sacral (MUG-Chor1, U-CH1) chordoma cell lines. Secretomes were analysed for receptor tyrosine kinase ligands (EGF, TGF-α, FGF-2 and VEGF-A) upon drug treatment.

Results

Drugs that were active as single agents (n = 45) included TKIs, HDAC and proteasome inhibitors, and cytostatic drugs. Six combinations were analysed in a matrix format: n = 4 resulted in a significantly increased cell killing (crizotinib, dabrafenib, panobinostat and doxorubicin), and n = 2 exhibited no or negligible effects (regorafenib, venetoclax). Clival chordoma cell lines were more responsive to combined EGFR-MET inhibition. EGFR-MET cross-talk (e.g. via TGF-α secretion) likely accounts for the synergistic effects of EGFR-MET inhibition.

Conclusion

Our screen revealed promising combinations with EGFRis, such as the ALK/MET-inhibitor crizotinib, the HDAC-inhibitor panobinostat or the topoisomerase-II-inhibitor doxorubicin, which are part of standard chemotherapy regimens for various bone and soft-tissue sarcomas.

SUBMITTER: Scheipl S 

PROVIDER: S-EPMC8648636 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC9801064 | biostudies-literature
| S-EPMC7360834 | biostudies-literature
| S-EPMC4924781 | biostudies-literature
| S-EPMC3602587 | biostudies-literature
| S-EPMC4589060 | biostudies-other
2013-04-01 | E-GEOD-33742 | biostudies-arrayexpress
| S-EPMC3127950 | biostudies-literature
| S-EPMC6170033 | biostudies-literature
| S-EPMC10311304 | biostudies-literature
| S-EPMC6956816 | biostudies-literature